NPR News: A Look At How The Revolving Door Spins From FDA To Industry

A Look At How The Revolving Door Spins From FDA To Industry
About 27 percent of Food and Drug Administration reviewers who approved hematology-oncology drugs from 2001 through 2010 left to work for the industry they previously regulated, an analysis found.

Read more on NPR
September 28, 2016 at 09:48PM
Health Care